PMID- 28755842 OWN - NLM STAT- MEDLINE DCOM- 20180808 LR - 20180808 IS - 1878-0334 (Electronic) IS - 1871-4021 (Linking) VI - 11 Suppl 2 DP - 2017 Dec TI - High serum ferritin levels are associated with insulin resistance but not with impaired glucose tolerance in a healthy people population. PG - S983-S988 LID - S1871-4021(17)30218-7 [pii] LID - 10.1016/j.dsx.2017.07.026 [doi] AB - AIM: To assess the association between elevated serum ferritin levels and the presence of insulin resistance (IR) or impaired glucose tolerance (IGT) in a population of individuals with no endocrine or metabolic disorders background. METHODS: Analytical cross-sectional study, carried out in adults of both sexes with no medical history of type 2 diabetes mellitus (T2DM) or other metabolic or endocrine disorder, who attended the outpatient service of a private clinic in Lima-Peru during 2012-2014 period. Impaired serum ferritin levels were defined as serum ferritin values >300mug/L in men and >200mug/L in women. IR was defined as a Homeostasis Model Assessment (HOMA-IR) value >/=3.8 and IGT was defined as an oral glucose tolerance test (OGTT) value between 126mg/dL and 199mg/dL. The reported association measure was the prevalence ratio (PR) with their respective 95% confidence intervals (95% CI). RESULTS: We analyzed 213 participants, the average age was 35.8+/-11.1years and 35.7% were males. The prevalence of impaired serum ferritin levels, IR and IGT in the population was 12.7%, 33.3% and 9.9% respectively. In the adjusted Poisson regression models, the prevalence of IR was higher among the group with impaired serum ferritin levels (PR=1.74; 95%CI:1.18-2.56); however, we found no association between impaired serum ferritin levels and IGT (PR=1.42; 95%CI:0.47-4.30). CONCLUSIONS: Impaired levels of serum ferritin are associated with IR, nevertheless, not with IGT in a metabolically healthy population. Serum ferritin could be considered as an early marker of IR prior to the onset of glycaemia disorders. CI - Copyright (c) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved. FAU - Aguirre, Luis G AU - Aguirre LG AD - Sociedad Cientifica de Estudiantes de Medicina de la Universidad de San Martin de Porres, Universidad de San Martin de Porres, Lima, Peru. FAU - Urrunaga-Pastor, Diego AU - Urrunaga-Pastor D AD - Sociedad Cientifica de Estudiantes de Medicina de la Universidad de San Martin de Porres, Universidad de San Martin de Porres, Lima, Peru. FAU - Moncada-Mapelli, Enrique AU - Moncada-Mapelli E AD - Sociedad Cientifica de Estudiantes de Medicina de la Universidad de San Martin de Porres, Universidad de San Martin de Porres, Lima, Peru. FAU - Guarnizo-Poma, Mirella AU - Guarnizo-Poma M AD - Instituto Medico de la Mujer, Instituto Medico Metabolico, Lima, Peru. FAU - Lazaro-Alcantara, Herbert AU - Lazaro-Alcantara H AD - Instituto Medico de la Mujer, Instituto Medico Metabolico, Lima, Peru. FAU - Benites-Zapata, Vicente A AU - Benites-Zapata VA AD - Centre for Public Health Research, Research Institute, Faculty of Medicine, Universidad de San Martin de Porres, Lima, Peru. Electronic address: vbeniteszapata@gmail.com. CN - Insulin Resistance and Metabolic Syndrome Research Group LA - eng PT - Journal Article DEP - 20170720 PL - Netherlands TA - Diabetes Metab Syndr JT - Diabetes & metabolic syndrome JID - 101462250 RN - 9007-73-2 (Ferritins) SB - IM MH - Adult MH - Cross-Sectional Studies MH - Female MH - Ferritins/*blood MH - Glucose Intolerance/*etiology MH - Humans MH - *Insulin Resistance MH - Male MH - Middle Aged OTO - NOTNLM OT - Adults OT - Ferritin OT - Glucose tolerance test OT - Insulin resistance EDAT- 2017/08/02 06:00 MHDA- 2018/08/09 06:00 CRDT- 2017/07/31 06:00 PHST- 2017/07/02 00:00 [received] PHST- 2017/07/16 00:00 [accepted] PHST- 2017/08/02 06:00 [pubmed] PHST- 2018/08/09 06:00 [medline] PHST- 2017/07/31 06:00 [entrez] AID - S1871-4021(17)30218-7 [pii] AID - 10.1016/j.dsx.2017.07.026 [doi] PST - ppublish SO - Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S983-S988. doi: 10.1016/j.dsx.2017.07.026. Epub 2017 Jul 20.